Can’t go based on anecdotal evidence unless there is clinical data which can’t be because we are the world’s first?
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%